Peter Houghton

Title: The Innovative Contributions of Peter Houghton

Introduction

Peter Houghton, an accomplished inventor based in Austin, Texas, has made significant contributions to the field of cancer research. With a focus on developing innovative methods for treating Ewing family tumors, Houghton has garnered recognition for his groundbreaking patent, which aims to improve patient outcomes in this challenging area of medicine.

Latest Patents

Peter Houghton holds a patent for "Altertoxin II as a selective inhibitor of Ewing family tumor cells." This patent outlines methods for treating Ewing family tumors (EFT) by administering an effective amount of altertoxin II to subjects diagnosed with EFT. His work addresses the urgent need for more effective therapies against this aggressive type of cancer.

Career Highlights

Throughout his career, Peter has held positions at notable institutions, including the University of Texas System and the University of Oklahoma. His role in these universities has allowed him to advance his research and contribute to the academic community's understanding of cancer therapies.

Collaborations

Peter has collaborated with esteemed colleagues such as Susan L. Mooberry and Andrew J. Robles. These partnerships have enhanced his research efforts and facilitated the development of innovative solutions to combat Ewing family tumors.

Conclusion

Peter Houghton is a prominent figure in the realm of cancer research and innovation. With his focus on developing targeted therapies for Ewing family tumors, his work continues to impact the medical community and offers hope for improved treatment options for patients battling this severe condition. Houghton's dedication and passion for advancing cancer research exemplify the spirit of innovation in the fight against cancer.